Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
Postpneumonectomy syndrome (PPS) is a rare complication of pneumonectomy due to an excessive mediastinal shift producing compression of the main bronchus or a lobe bronchus on the aorta or the spine. We report an exceptional case in which an extreme mediastinal shift was due to fibrosis and complete atelectasis of the left lung, as a complication of chemoradiation treatment for recurrent mediastinal Hodgkin's lymphoma. This condition, associated with a further recurrence of the disease, indicated a postpneumonectomy-like syndrome.
Veronesi
G
G
Thoracic Surgery Division, European Institute of Oncology, Milano, Italy. giulia.veronesi@ieo.it
Spaggiari
L
L
Solli
P G
PG
Leo
F
F
Villa
G
G
Pastorino
U
U
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008168:Lung / Q000187:drug effects* / Q000528:radiation effects*; D008466:Mechlorethamine / Q000008:administration & dosage / Q000009:adverse effects; D011013:Pneumonectomy; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D013902:Radiography, Thoracic; D011878:Radiotherapy / Q000009:adverse effects; D012128:Respiratory Distress Syndrome / Q000175:diagnosis / Q000209:etiology*; D012129:Respiratory Function Tests; D018570:Risk Assessment; D012720:Severity of Illness Index; D013577:Syndrome; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone